Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the release of a thematic report that examines small market cap pharmaceutical companies based on revenue growth and valuation. The report: Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline examines that represents the top 0.1 percentile of small pharmaceutical growth companies.
To view the full announcement, including downloadable images, bios, and more, click here.
- The market intelligence report identifies a group of small-cap healthcare companies that we believe represent small, undervalued businesses with room to grow in the current biotech industry downturn.
- The report highlights standout companies including -- Alimera Sciences, Inc. (NASDAQ: ALIM), Assertio Holdings, Inc. (NASDAQ: ASRT), Aytu BioPharma, Inc. (NASDAQ: AYTU), Evolus, Inc. (NASDAQ: EOLS), and Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) -- that not only show strong revenue growth but also low enterprise value to sales ratios.
Click image above to view full announcement.
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.
Stonegate Capital Partners
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/176474